The American Academy of Arts and Sciences elected 213 new members, including some of the world's most accomplished scholars, scientists, writers, artists, as well as civic, business, and philanthropic leaders.
NANCY DAVIDSON was inaugurated as president of the American Association for Cancer Research for 2016-2017 at the association's annual meeting in New Orleans.
ROBERT WEINBERG was honored for his contributions to cancer research and cancer biology with the 13th annual AACR Award for Lifetime Achievement in Cancer Research. Weinberg is a founding member of the Whitehead Institute for Biomedical Research; the Daniel K. Ludwig professor for cancer research in the Department of Biology at the Massachusetts Institute of... […]
A phase III trial will be needed to determine approvability of the Clovis Oncology Inc. agent rociletinib for the treatment of non-small cell lung cancer, the FDA Oncologic Drugs Advisory Committee recommended.
THE INTERNATIONAL MYELOMA FOUNDATION will fund a large-scale screening study for preventing myeloma. iStopMM, for Iceland Screens Treats or Prevents Multiple Myeloma, will examine blood samples from approximately 140,000 adults over age 40 in Iceland for the earliest signs of myeloma. Nearly all Icelandic citizens over age 40 already have routine blood tests, according to... […]
FDA granted accelerated approval to Venclexta tablets (venetoclax) for patients diagnosed with chronic lymphocytic leukemia with 17p deletion, as detected by an FDA-approved test, who have received at least one prior therapy.
FDA granted priority review for atezolizumab (MPDL3280A) for the treatment of people with locally advanced or metastatic non-small cell lung cancer whose disease expresses the protein PD-L1, as determined by an FDA-approved test, and who have progressed on or after platinum-containing chemotherapy. “In a study of atezolizumab in people with previously treated advanced lung cancer,... […]
FDA approved Epi proColon, a blood-based colorectal cancer screening test developed by Epigenomics AG. Epi proColon will be made available in the U.S. under a joint commercialization agreement with Epigenomics partner Polymedco. Epi proColon is indicated for colorectal cancer screening in average-risk patients who choose not to undergo colorectal cancer screening by guideline-recommended methods such... […]
THE UNIVERSITY OF FLORIDA Health Proton Therapy Institute signed a contract with Ion Beam Applications to install a Proteus One system and to upgrade its current proton therapy equipment. The contract also includes an operation and maintenance agreement for the Proteus One system. In total, the contract is worth approximately $30 million to IBA. The... […]
THE UNIVERSITY OF CALIFORNIA, DAVIS and Novogene established a genomics sequencing center on the university’s Sacramento campus. Novogene purchased its second Illumina Hi-Seq X Ten system, which can perform whole human genome sequencing for less than $1,000, and will install five sequencers in the new facility, scheduled to open in early May. The center will... […]
